https://www.selleckchem.com/pr....oducts/b102-parp-hda
To analyse the role of multiparametric magnetic resonance imaging (mpMRI) ultrasound (US)-guided fusion biopsy (F in patients with low-risk prostate cancer (PCa) under active surveillance (AS). Our retrospective study included 47 patients under AS who consecutively underwent both FB and standard biopsy (S, from May 2015 until November 2017. We defined FB as a transrectal US-guided biopsy based on mpMRI. The primary endpoint was to assess the rate of concordance between FB and SB in terms of diagnostic yield, as well as t
Like
Comment
Share
